Scholar Rock Holding Corp. (SRRK)

48.50 +0.78 (+1.63%) USD  |  NASDAQ  |  May 22, 09:44
More

Scholar Rock Cash and Equivalents (Quarterly)

Cash and Equivalents (Quarterly) Chart

View Cash and Equivalents (Quarterly) for SRRK.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Equivalents (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Cash and Equivalents (Quarterly) Range, Past 5 Years

View Cash and Equivalents (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Equivalents (Quarterly) Benchmarks

View Cash and Equivalents (Quarterly) Benchmarks
Start Trial
Krystal Biotech, Inc. Upgrade
Stoke Therapeutics, Inc. Upgrade
Biogen, Inc. Upgrade
Apellis Pharmaceuticals, Inc. Upgrade
Zymeworks, Inc. Upgrade